您的当前位置:首页 > 行业数据 > 安罗替尼已推进到III期临床适应症(截至2025年7月20日)
图片属性
图片格式:PNG 图片大小:332KB 图片尺寸:2303*1390
同报告图片
 / 4
安罗替尼已推进到III期临床适应症(截至2025年7月20日)_第1页
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
安罗替尼已推进到III期临床适应症(截至2025年7月20日)_第2页
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
安罗替尼已推进到III期临床适应症(截至2025年7月20日)_第3页
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
安罗替尼已推进到III期临床适应症(截至2025年7月20日)_第4页
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
安罗替尼已推进到III期临床适应症(截至2025年7月20日)_第5页
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
所属报告: 中国生物制药(1177.HK)-港股公司研究报告:创新管线价值重估制药龙头华丽转身-250731(76页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠